Wanbangde Pharmaceutical Holding Group Co.,Ltd.’s Net Profit Dropped 20% in First Quarter of 2022

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) (002082.SZ) reported a net profit of 21.7 million yuan in the first quarter of 2022, down 20% year-on-year.

Meanwhile, the company posted 332.6 million yuan in revenue, down 42.8% year-on-year.

At the end of the reporting period, it had 4.2 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 33.3%.